☆ 4.8 Letter

Empagliflozin and Major Renal Outcomes in Heart Failure

NEW ENGLAND JOURNAL OF MEDICINE (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cardiac & Cardiovascular Systems

Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Results of DAPA-HF

Pardeep S. Jhund et al.

Summary: The study found that dapagliflozin had consistent safety and efficacy in patients with heart failure and reduced ejection fraction regardless of kidney function status, and it could slow down the decline in eGFR. This effect was observed in patients with and without diabetes.

CIRCULATION (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Exercise for Frail, Elderly Patients with Acute Heart Failure - A Strong Step Forward

Stefan D. Anker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Pitfalls in Using Estimated Glomerular Filtration Rate Slope as a Surrogate for the Effect of Drugs on the Risk of Serious Adverse Renal Outcomes in Clinical Trials of Patients With Heart Failure

Milton Packer

CIRCULATION-HEART FAILURE (2021)

添加到收藏夹

Article Medicine, General & Internal

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Milton Packer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Design of a prospective patient-level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure

Milton Packer et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.